Eisai Beats Whistleblower's Off-Label Marketing FCA Suit
A Florida federal judge on Friday tossed an employee whistleblower's False Claims Act suit accusing pharmaceutical company Eisai Inc. of promoting off-label uses for its drugs and paying medical providers to...To view the full article, register now.
Already a subscriber? Click here to view full article